tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Oncopeptides Partners with SD Pharma to Expand Pepaxti Reach in Spain

Story Highlights
  • Oncopeptides partners with SD Pharma to expand Pepaxti’s reach in Spain.
  • The collaboration aims to enhance Oncopeptides’ presence in Spanish hospitals, advancing cancer treatment goals.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Oncopeptides Partners with SD Pharma to Expand Pepaxti Reach in Spain

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Oncopeptides AB ( (SE:ONCO) ) has provided an update.

Oncopeptides AB has announced a strategic partnership with SD Pharma to expand the reach of its flagship drug, Pepaxti, in Spain. This collaboration aims to enhance Oncopeptides’ commercial presence in Spanish hospitals, leveraging SD Pharma’s expertise in oncology and hematology. The partnership is expected to significantly advance Oncopeptides’ goal of addressing unmet medical needs in the cancer treatment landscape, with activities commencing in Q3 2025 on a success-based model.

More about Oncopeptides AB

Oncopeptides AB is a Swedish biotech company specializing in the research, development, and commercialization of targeted therapies for difficult-to-treat cancers. Utilizing its proprietary Peptide Drug Conjugate platform, the company develops compounds that deliver cytotoxic agents into cancer cells. Oncopeptides’ flagship drug, Pepaxti, is being commercialized in Europe, with partnerships extending to South Korea, the Middle East, and Africa. Founded in 2000, the company operates in several European countries and is listed on Nasdaq Stockholm.

Average Trading Volume: 3,836,944

Technical Sentiment Signal: Buy

Current Market Cap: SEK1.21B

Find detailed analytics on ONCO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1